Literature DB >> 3166028

Steroidal regulation of oestradiol-17 beta dehydrogenase activity of the human breast cancer cell line MCF-7.

E F Adams1, N G Coldham, V H James.   

Abstract

We have examined the direct effects of progestins, oestrogens, peptide hormones and growth factors on oestradiol-17 beta dehydrogenase (OE2DH) activity of cultures of the human breast cancer cell line MCF-7. Cells were cultured in the presence of steroid or peptide for 6 days, after which the number of cells was determined and cellular OE2DH activity assessed. Progesterone, 6 alpha-methyl-17 alpha-hydroxyprogesterone acetate, norethisterone and D(-)-norgestrel all profoundly inhibited cell mitosis and stimulated reductive (oestrone----oestradiol-17 beta) and oxidative (oestradiol-17 beta----oestrone) OE2DH activity. Both oestrone and oestradiol-17 beta directly stimulated reductive OE2DH activity, but had no effect on the oxidative direction. Oestradiol-17 beta stimulated cell growth only in phenol-red free culture medium. Ovine prolactin, LH, epidermal growth factor and transforming growth factor did not alter OE2DH activity but small stimulatory effects on the growth of MCF-7 cells were exerted by prolactin and a combination of transforming growth factor with epidermal growth factor. It is concluded that these results may explain, at least in part, the alterations in mitotic activity and tissue oestradiol-17 beta levels observed in breast tissue during varying physiological and pathological conditions, such as during the menstrual cycle and in breast cancers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166028     DOI: 10.1677/joe.0.1180149

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

Review 1.  Enzymatic regulation of estradiol-17 beta concentrations in human breast cancer cells.

Authors:  J B Adams
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

2.  Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.

Authors:  S Li; C Lévesque; C S Geng; X Yan; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

3.  Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).

Authors:  B L Nguyen; G Chetrite; J R Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

4.  Regulation of estrogen sulfotransferase by estrogen in MCF-7 human mammary cancer cells.

Authors:  J B Adams; R Vrahimis; N Phillips
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression.

Authors:  M M Miettinen; M V Mustonen; M H Poutanen; V V Isomaa; R K Vihko
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

6.  Molecular cloning of a novel widely expressed human 80 kDa 17 beta-hydroxysteroid dehydrogenase IV.

Authors:  J Adamski; T Normand; F Leenders; D Monté; A Begue; D Stéhelin; P W Jungblut; Y de Launoit
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

7.  17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters.

Authors:  T Suzuki; T Moriya; N Ariga; C Kaneko; M Kanazawa; H Sasano
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

8.  Short-term primary culture of epithelial cells derived from human breast tumours.

Authors:  V Speirs; A R Green; D S Walton; M J Kerin; J N Fox; P J Carleton; S B Desai; S L Atkin
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.